Discover

MLAB
Mesa Laboratories, Inc.
104.39
2 x 75.03
2 x 127.39
bid
ask
+
4.84
4.86%
2 @ 04:00 PM
108.47 +4.08 (3.91%)
Ytd32.98%
1y6.84%
99.53
day range
106.12
55.45
52 week range
113.99
Open99.53Prev Close99.55Low99.53High106.12Mkt Cap576.75M
Vol142.21KAvg Vol173.56KEPS1.21P/E86.27Forward P/E18.42
Beta0.86Short Ratio3.64Inst. Own91.88%Dividend0.64Div Yield0.48
Ex Div Date11-29Earning08-0550-d Avg101.83200-d Avg86.391yr Est133.33
Earning
DateForEstimateReportedSurprisesurprise %
2025-02-032024-122.45N/AN/AN/A
2024-11-072024-092.482.45-0.03-1.21%
2024-08-052024-062.332.830.521.46%
2024-02-052023-122.042.02-0.02-0.98%
2023-11-062023-091.651.910.2615.76%
2023-08-032023-061.671.770.15.99%
Upgrade / Downgrade
DateFirmActionFromTo
2024-10-01Evercore ISI GroupUpgradeOutperformOutperform
2024-08-27Wells FargoUpgradeUnderweight
2024-08-06Evercore ISI GroupUpgradeOutperformOutperform
2024-07-02Evercore ISI GroupUpgradeOutperformOutperform
2024-04-04Evercore ISI GroupUpgradeOutperformOutperform
2024-01-04Evercore ISI GroupUpgradeIn-LineOutperform
Profile
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Insider Holder
DateNameRelationQuantityDescription
2024-08-29ALLTOFT JENNIFER SADIEDirector3.47KConversion of Exercise of derivative security
2024-09-12ARCHBOLD BRIAN DAVIDOfficer0.00Sale
2024-08-14CAPONE MARK CHRISTOPHERDirector724.00Conversion of Exercise of derivative security
2024-08-29HALL SHANNONDirector2.79KConversion of Exercise of derivative security
2024-08-29LADIWALA SHIRAZ SHABANALIDirector3.07KConversion of Exercise of derivative security
2024-10-28OWENS GARY MChief Executive Officer43.34KSale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Blackrock Inc.836.82K113.31M15.41%
2024-09-29Conestoga Capital Advisors, LLC529.11K71.64M9.74%
2024-09-29Vanguard Group Inc377.58K51.12M6.95%
2024-09-29Royce & Associates LP347.15K47.00M6.39%
2024-09-29Morgan Stanley249.35K33.76M4.59%
2024-09-29Ranger Investment Management, L.p.238.19K32.25M4.39%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Conestoga Small Cap Fund363.99K49.28M6.70%
2024-10-30iShares Core S&P Smallcap ETF343.77K46.55M6.33%
2024-09-29Vanguard Total Stock Market Index Fund159.57K21.61M2.94%
2024-10-30iShares Russell 2000 ETF131.95K17.87M2.43%
2024-09-29Royce Small-Cap Fund104.55K14.16M1.92%
2024-09-29Royce Micro Cap Trust104.13K14.10M1.92%
Dividend
DividendDate
0.162026-05-29
0.162026-02-27
0.162025-11-28
0.162025-08-29
0.162025-05-30
0.162025-02-28